+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Novacyt SA (ALNOV) - Product Pipeline Analysis, 2019 Update

  • ID: 4721923
  • Company Profile
  • 40 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Acanthe Biotech
  • Adebiotech
  • AgCom biotech S.A.R.L.
  • Eurobio Scientific SA
  • Medtech SA
  • MORE
Summary

Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt develops proprietary technology platform NOVAPREP, a next generation liquid based cytology solution focused on cancer management. The company’s cytology solution is also used in medical laboratories for diagnoses of diseases based on the study of organs and tissues on a molecular level. It has operations in France and the UK. Novacyt is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Novacyt SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Acanthe Biotech
  • Adebiotech
  • AgCom biotech S.A.R.L.
  • Eurobio Scientific SA
  • Medtech SA
  • MORE
Novacyt SA Company Overview
  • Novacyt SA Company Snapshot
  • Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview
  • Novacyt SA – Pipeline Analysis Overview
  • Novacyt SA - Key Facts
  • Novacyt SA - Major Products and Services
  • Novacyt SA Pipeline Products by Development Stage
  • Novacyt SA Pipeline Products Overview
  • Diagnostic Assay - Aspergillus
  • Diagnostic Assay - Aspergillus Product Overview
  • Diagnostic Assay - Pneumocystis
  • Diagnostic Assay - Pneumocystis Product Overview
  • Genesig - Cytomegalovirus Test
  • Genesig - Cytomegalovirus Test Product Overview
  • Genesig Kit - Human Papillomavirus 14
  • Genesig Kit - Human Papillomavirus 14 Product Overview
  • Genesig Kit - Zika Virus
  • Genesig Kit - Zika Virus Product Overview
  • Genesig q24
  • Genesig q24 Product Overview
  • Multiplex Test - Mosquito-Borne Diseases
  • Multiplex Test - Mosquito-Borne Diseases Product Overview
  • Next Generation NOVAPrep
  • Next Generation NOVAPrep Product Overview
  • Onconostica
  • Onconostica Product Overview
  • Single Nucleotide Polymorphism Assay
  • Single Nucleotide Polymorphism Assay Product Overview
  • Novacyt SA - Key Competitors
  • Novacyt SA - Key Employees
  • Novacyt SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Novacyt SA, Recent Developments
  • Jul 30, 2019: Novacyt announces Half-Year Trading Update
  • May 13, 2019: Novacyt announces launch of next-generation qPCR instrument
  • Apr 30, 2019: Novacyt full year 2018 results
  • Apr 08, 2019: Novacyt expands development partnership with Immunexpress
  • Feb 26, 2019: Novacyt: Funding update
  • Feb 12, 2019: Molecular diagnostic tests genesig Real-Time PCR BKV Kit (CE) and genesig Real-Time PCR EBV Kit (CE) to help transplantation and immunosuppressed patients
  • Jan 22, 2019: Novacyt revenues full year 2018
  • Dec 21, 2018: Novacyt launches two new CE-IVD marked molecular diagnostic kits
  • Dec 11, 2018: Novacyt announces update on strategic review of non-core assets
  • Dec 06, 2018: Completion of substantial q16 molecular diagnostics order expands clinical diagnostic reach in fast growing Chinese market
Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview
  • Novacyt SA Pipeline Products by Equipment Type
  • Novacyt SA Pipeline Products by Indication
  • Novacyt SA, Key Facts
  • Novacyt SA, Major Products and Services
  • Novacyt SA Number of Pipeline Products by Development Stage
  • Novacyt SA Pipeline Products Summary by Development Stage
  • Diagnostic Assay - Aspergillus - Product Status
  • Diagnostic Assay - Aspergillus - Product Description
  • Diagnostic Assay - Pneumocystis - Product Status
  • Diagnostic Assay - Pneumocystis - Product Description
  • Genesig - Cytomegalovirus Test - Product Status
  • Genesig - Cytomegalovirus Test - Product Description
  • Genesig Kit - Human Papillomavirus 14 - Product Status
  • Genesig Kit - Human Papillomavirus 14 - Product Description
  • Genesig Kit - Zika Virus - Product Status
  • Genesig Kit - Zika Virus - Product Description
  • Genesig q24 - Product Status
  • Genesig q24 - Product Description
  • Multiplex Test - Mosquito-Borne Diseases - Product Status
  • Multiplex Test - Mosquito-Borne Diseases - Product Description
  • Next Generation NOVAPrep - Product Status
  • Next Generation NOVAPrep - Product Description
  • Onconostica - Product Status
  • Onconostica - Product Description
  • Single Nucleotide Polymorphism Assay - Product Status
  • Single Nucleotide Polymorphism Assay - Product Description
  • Novacyt SA, Key Employees
  • Novacyt SA, Subsidiaries
  • Glossary
List of Figures
  • Novacyt SA Pipeline Products by Equipment Type
  • Novacyt SA Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtech SA
  • Mauna Kea Technologies SAS
  • Eurobio Scientific SA
  • Anagenesis Biotechnologies SAS
  • AgCom biotech S.A.R.L.
  • Adebiotech
  • Acanthe Biotech
Note: Product cover images may vary from those shown
Adroll
adroll